The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients?

Acta Neurologica Scandinavica

Volumn 97, Issue 3, 1998, Pages 171-174

  Munch, M ^a   Riisom, K ^b   Christensen, T ^a   Moller Larsen A ^a   Haahr, S ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Epstein Barr virus; Multiple sclerosis; Serology

Indexed keywords

ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; GENETIC DISORDER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION RISK; MULTIPLE SCLEROSIS; SEROCONVERSION; VIRUS INFECTION; VIRUS REACTIVATION;

EID: 0031779318     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1998.tb00632.x     Document Type: Article

References (21)

1. RICKINSON AB, KIEF E. Epstein-Barr virus. In: FIELDS BN, KNIPE DM, HOWLEY PM, eds. Fields Virology. 3rd edn. Philadelphia and New York: Lippincott-Raven Publishers 1996: 2397-446.
2. EVANS AS, NIEDERMAN JC. Epstein-Barr Virus. In: EVANS AS, ed. Viral Infections of Humans. Epidemiology and Controls. 3rd edn. New York and London: Plenum Medical Book Company 1989: 265-92.
3. STRAUS SE. Epstein-Barr virus infections: Biology, pathogenesis, and management. Ann Intern Med 1992: 118: 45-58.
4. STEINMAN L. Presenting an odd autoantigen. Nature 1995: 375: 739-40.
5. NORONHA A, ARNASON B. Demyelinating diseases. In: RICH RR, ed. Clinical Immunology Principles and Practice. St Louis: Mosby, 1996: 1364-76.
6. KURTZKE JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993: 6: 382-427.
7. MARTYN C. The epidemiology of multiple sclerosis. In: MATTHEWS WB, ed. McAlpine's multiple sclerosis. 2nd edn. Edinburgh: Churchill Livingstone, 1991: 3-40.
8. RIISE T, GRØNNING M, KLAUBER MR, BARRETT-CONNOR E, NYLAND H, ALBREKTSEN G. Clustering of residence of multiple sclerosis patients at age 13-20 years in Hordaland, Norway. Am J Epidemiol 1991: 133: 932-9.
9. HAAHR S, KOCH-HENRIKSEN N, MØLLER-LARSEN A, ERIKSEN LS, ANDERSEN HMK. Increased risk of multiple sclerosis after late Epstein-Barr virus infection. Multiple Sclerosis: Clin Lab Res 1995: 1: 73-7.
10. GALE CR, MARTYN C. Migrant studies in multiple sclerosis. Progress in Neurobiology 1995: 47: 425-48.
11. SUMAYA CV, MYERS LW, ELLISON GW. Epstein-Barr virus antibodies in multiple sclerosis. Arch Neurol 1980: 38: 94-6.
12. BRAY PF, BLOOMER LC, SALMON VC, BAGLEY MH, LARSEN PD. Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 1983: 37: 94-6.
13. SUMAYA CV, MYERS LW, ELLISON GW, ENCH Y. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 1985: 17: 371-7.
14. LARSEN PD, BLOOMER LC, BRAY PF. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology 1985: 35: 435-8.
15. TELENTI A, UEHLINGER DE, MARCHESI F, GERMANN D, MALINVERNI R, MATTER L. Epstein-Barr virus infection in HIV-positive patients. Eur J Clin Microbiol 1993: Infect Dis 1993: 12: 601-9.
16. GORGIEVSKI-HRISOHO M, MINDERER W, NEBEL-SCHICKEL H et al. Serodiagnosis of infectious mononucleosis by using recombinant Epstein-Barr virus antigens and enzyme-linked immunosorbent assay technology. J Clin Microbiol 1990: 28: 2305-11.
17. FARBER I, WUTZLER P, WOHLRABE P, WOLF H, HINDERER W, SONNEBORN HH. Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs. J Virol Methods 1993: 42: 301-7.
18. WEBER B, BRUNNER M, PREISER W, DOERR HW. Evaluation of 11 enzyme immunoassays for the detection of Immunoglobolin M antibodies to Epstein-Barr virus. J Virol Methods 1996: 57: 87-93.
19. KURTZKE JF, BEEBE GB, NORMAN JE. Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS. Neurology 1985: 35: 672-8.
20. HAAHR S, MUNCH M, CHRISTENSEN T, MØLLER-LARSEN A, HVAS J. Cluster of multiple sclerosis patients from Danish community. The Lancet 1997: 349: 923.
21. MUNCH M, HVAS J, CHRISTENSEN T, MØLLER-LARSEN A, HAAHR S. The implications of Epstein-Barr virus in multiple sclerosis - a review. Acta Neurol Scand 1997: (Suppl. 169) 59-64.